Manufacturing Gets a Lab Coat
South Carolina manufacturing has long been easy to picture: cars, tires, aircraft. Now add plasma-derived medicines, biotech laboratories and a $1.5 billion Rock Hill project to an industrial identity that is getting considerably harder to stereotype.
The clearest sign arrived in August, when Octapharma received final approval for its first U.S. manufacturing and production facility. The Swiss biopharmaceutical company plans to invest $1.5 billion at Palmetto Research Park in Rock Hill, with more than 1,500 projected jobs and operations expected to begin in the mid-2030s.
What will eventually roll through this production line will look very different from an SUV. Octapharma develops medicines based on proteins derived from human plasma and human cell lines, putting highly technical pharmaceutical production alongside the machinery-heavy manufacturing South Carolina is better known for.
A Different Kind of Factory Floor
The Rock Hill project is large enough to make headlines, but the more interesting story is what has been building around it.
The South Carolina Department of Commerce identifies life sciences as the state’s fastest-growing sector and one of three industries selected for long-term economic-development focus. The department says the industry has a $25.7 billion annual economic impact, includes more than 1,000 life-sciences companies and employs nearly 88,000 South Carolinians.
That puts laboratories, pharmaceutical operations, medical manufacturing and research increasingly within the same economic conversation as automobiles and aerospace.
It also changes what “manufacturing job” can mean. Life sciences connects production with research, hospitals, biotechnology and increasingly specialized technical skills. The factory floor has not disappeared. In some corners of the state, it has simply picked up a lab coat.
S.C. Commerce’s “Advancing Life Sciences, from Launch to Legacy” initiative makes clear that state leaders see this as more than a run of individual company announcements. Life sciences has been folded into a broader strategy for where South Carolina wants its economy to grow next.
Octapharma’s Rock Hill facility will take years to reach production, so its impact will not arrive overnight. Still, a $1.5 billion commitment offers a pretty substantial clue about where industry is headed.
South Carolina will continue building cars, aircraft and tires. Increasingly, though, some of the state’s most important manufacturing may be measured in doses rather than horsepower.
To see more of the companies shaping what South Carolina makes, explore the Guide to South Carolina manufacturing directory at https://guidetosouthcarolina.com/manufacturing.